Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor J Marder

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Thrombosis Research|August 30, 2008
Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activatorVictor J Marder
Thrombosis and Haemostasis|May 15, 2002
Maximized hemostasisVictor J Marder
Thrombosis Research|August 4, 2005
The interaction of dietary supplements with antithrombotic agents: scope of the problemVictor J Marder
Thrombosis Research|March 24, 2009
Thrombolytic therapy for deep vein thrombosis: potential application of plasminVictor J Marder
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Thrombosis Research|October 18, 2005
Conference summary and recommendations for researchAhmed A K Hasan, Victor J Marder
Best Practice & Research. Clinical Haematology|June 3, 2004
Foundation and sites of action of antithrombotic agentsVictor J Marder, Michael H Rosove, Dena M Minning
Thrombosis and Haemostasis|January 10, 2009
On the significance of marginally low von Willebrand factorPall T Onundarson, Brynja R Gudmundsdottir, Victor J Marder
Stroke|September 30, 2010
Thrombolysis with plasmin: implications for stroke treatmentVictor J Marder, Reza Jahan, Theresa Gruber, et al.
Blood|November 26, 2002
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageDaphne Stewart, Mansze Kong, Valery Novokhatny, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis Research|August 30, 2008
Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activatorVictor J Marder
Thrombosis and Haemostasis|May 15, 2002
Maximized hemostasisVictor J Marder
Thrombosis Research|August 4, 2005
The interaction of dietary supplements with antithrombotic agents: scope of the problemVictor J Marder
Thrombosis Research|March 24, 2009
Thrombolytic therapy for deep vein thrombosis: potential application of plasminVictor J Marder
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Thrombosis Research|October 18, 2005
Conference summary and recommendations for researchAhmed A K Hasan, Victor J Marder
Best Practice & Research. Clinical Haematology|June 3, 2004
Foundation and sites of action of antithrombotic agentsVictor J Marder, Michael H Rosove, Dena M Minning
Thrombosis and Haemostasis|January 10, 2009
On the significance of marginally low von Willebrand factorPall T Onundarson, Brynja R Gudmundsdottir, Victor J Marder
Stroke|September 30, 2010
Thrombolysis with plasmin: implications for stroke treatmentVictor J Marder, Reza Jahan, Theresa Gruber, et al.
Blood|November 26, 2002
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageDaphne Stewart, Mansze Kong, Valery Novokhatny, et al.
Pageof 4